InsidersTradesSigma
Total declarations
Company
▲ Purchases (5 ops.)
▼ Sales (0 ops.)
Insider track record
CFODisclosed buys
5
Disclosed sells
0
T+90 hit rate
33%
T+90 mean return
+8.5%
Across 3 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the full record of transactions filed by Whaley Glenn, Chief Financial Officer. Director active across 1 company, notably Immunic, INC.. Aggregated, 6 reports have been logged. Split: 5 buys · 0 sell. Total volume traded: €53k. Activity tracked since 10 August 2021. The latest transaction was filed on 30 May 2025 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
Companies and markets linked to Whaley Glenn
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations6 total
25,000 shares@ US$0.5618.9% of flowCommon StockSEC:0001193805-25-000788:0
5,000 shares@ US$1.7512.3% of flowCommon StockSEC:0001193805-23-000735:0
Canonical exit: 13 Aug 2023 (T+90)
5,000 shares@ US$1.49511.5% of flowCommon StockSEC:0001193805-22-001497:0
Canonical exit: 5 Feb 2023 (T+90)
3,500 shares@ US$3.04515.2% of flowCommon StockSEC:0001193805-22-000918:0
Canonical exit: 1 Sept 2022 (T+90)
3,000 shares@ US$5.0822.6% of flowCommon StockSEC:0001193805-22-000788:0
Canonical exit: 10 Aug 2022 (T+90)
1,500 shares@ US$9.8519.4% of flowCommon StockSEC:0001193805-21-001163:0
Canonical exit: 8 Nov 2021 (T+90)
6 of 6 declarations
About Whaley Glenn
Glenn Whaley is the Chief Financial Officer at Immunic, Inc. He oversees the financial operations of the company, including budgeting and risk management. His role is crucial in ensuring the financial health and growth of the company.
